Degenerative Disc Disease, Lumbar
9
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Biologic Injection For Adults With Lumbar Disc Herniation
Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF)
Fusion or Not - a Study on Low Back Pain
CELZ-201-DDT for the Treatment of Chronic Lower Back Pain
Facet Tropism in Low Back Pain Patients
A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages in the Lumbar Spine
FLXfit Post Market Outcome Study Protocol
Multimodal Analgesia Versus Routine Care Pain Management
Satellite™ PEEK Nucleus Replacement Retrospective Analysis